Regulation of peroxisome proliferator-activated receptors by E6-associated protein

PPAR Research

Volumn , Issue , 2008, Pages

  Gopinathan, Lakshmi ^a,b   Hannon, Daniel B ^b   Smith III, Russell W ^b   Peters, Jeffrey M ^b   Vanden Heuvel, John P ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; E6 ASSOCIATED PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEASOME; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BLOCKING;

EID: 58149163309     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/746935     Document Type: Article

References (37)

1. Feige J. N., Gelman L., Michalik L., Desvergne B., Wahli W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions Progress in Lipid Research 2006 45 2 120 159
2. Desvergne B., Michalik L., Wahli W., Be fit or be sick: peroxisome proliferator-activated receptors are down the road Molecular Endocrinology 2004 18 6 1321 1332
3. Escher P., Wahli W., Peroxisome proliferator-activated receptors: insight into multiple cellular functions Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2000 448 2 121 138
4. Yu S., Reddy J. K., Transcription coactivators for peroxisome proliferator-activated receptors Biochimica et Biophysica Acta 2007 1771 8 936 951
5. Glass C. K., Rosenfeld M. G., The coregulator exchange in transcriptional functions of nuclear receptors Genes and Development 2000 14 2 121 141
6. Ismail A., Nawaz Z., Nuclear hormone receptor degradation and gene transcription: an update IUBMB Life 2005 57 7 483 490
7. Kinyamu H. K., Chen J., Archer T. K., Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors Journal of Molecular Endocrinology 2005 34 2 281 297
8. Rochette-Egly C., Dynamic combinatorial networks in nuclear receptor-mediated transcription The Journal of Biological Chemistry 2005 280 38 32565 32568
9. Matsuura T., Sutcliffe J. S., Fang P., De novo truncating mutations in E6-Ap ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome Nature Genetics 1997 15 1 74 77
10. Smith C. L., DeVera D. G., Lamb D. J., Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction Molecular and Cellular Biology 2002 22 2 525 535
11. Nawaz Z., Lonard D. M., Smith C. L., The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily Molecular and Cellular Biology 1999 19 2 1182 1189
12. Mani A., Oh A. S., Bowden E. T., E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells Cancer Research 2006 66 17 8680 8686
13. Munakata T., Liang Y., Kim S., Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein PLoS Pathogens 2007 3 9 1335 1347
14. Scheffner M., Huibregtse J. M., Vierstra R. D., Howley P. M., The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 Cell 1993 75 3 495 505
15. Liu Y., Baleja J. D., Structure and function of the papillomavirus E6 protein and its interacting proteins Frontiers in Bioscience 2008 13 1 121 134
16. Tien E. S., Davis J. W., Vanden Heuvel J. P., Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor α coregulator The Journal of Biological Chemistry 2004 279 23 24053 24063
17. Gray J. P., Davis J. W. II, Gopinathan L., Leas T. L., Nugent C. A., Vanden Heuvel J. P., The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor- α Toxicological Sciences 2006 89 2 535 546
18. Lee S. S.-T., Pineau T., Drago J., Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Molecular and Cellular Biology 1995 15 6 3012 3022
19. Tien E. S., Gray J. P., Peters J. M., Vanden Heuvel J. P., Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor α -dependent growth regulatory genes Cancer Research 2003 63 18 5767 5780
20. Kinyamu H. K., Archer T. K., Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in Mdm2 protein expression Molecular and Cellular Biology 2003 23 16 5867 5881
21. Burger A. M., Gao Y., Amemiya Y., A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer Cancer Research 2005 65 22 10401 10412
22. Zhang J., Guenther M. G., Carthew R. W., Lazar M. A., Proteasomal regulation of nuclear receptor corepressor-mediated repression Genes and Development 1998 12 12 1775 1780
23. Blanquart C., Barbier O., Fruchart J.-C., Staels B., Glineur C., Peroxisome proliferator-activated receptor α (PPAR α) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes The Journal of Biological Chemistry 2002 277 40 37254 37259
24. Blanquart C., Mansouri R., Fruchart J.-C., Staels B., Glineur C., Different ways to regulate the PPAR α stability Biochemical and Biophysical Research Communications 2004 319 2 663 670
25. Genini D., Catapano C. V., Block of nuclear receptor ubiquitination: a mechanism of ligand-dependent control of peroxisome proliferator-activated receptor δ activity The Journal of Biological Chemistry 2007 282 16 11776 11785
26. Rieck M., Wedeken L., Müller-Brüsselbach S., Meissner W., Müller R., Expression level and agonist-binding affect the turnover, ubiquitination and complex formation of peroxisome proliferator activated receptor β FEBS Journal 2007 274 19 5068 5076
27. Hauser S., Adelmant G., Sarraf P., Wright H. M., Mueller E., Spiegelman B. M., Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation The Journal of Biological Chemistry 2000 275 24 18527 18533
28. Conaway R. C., Brower C. S., Conaway J. W., Emerging roles of ubiquitin in transcription regulation Science 2002 296 5571 1254 1258
29. Reid G., Hübner M. R., Métivier R., Cyclic, proteasome-mediated turnover of unliganded and liganded ER α on responsive promoters is an integral feature of estrogen signaling Molecular Cell 2003 11 3 695 707
30. Qi J.-S., Yuan Y., Desai-Yajnik V., Samuels H. H., Regulation of the mdm2 oncogene by thyroid hormone receptor Molecular and Cellular Biology 1999 19 1 864 872
31. Zhao B.-X., Chen H.-Z., Lei N.-Z., p53 mediates the negative regulation of MDM2 by orphan receptor TR3 The EMBO Journal 2006 25 24 5703 5715
32. Huang W., Zhang J., Washington M., Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor Molecular Endocrinology 2005 19 6 1646 1653
33. Shirakura M., Murakami K., Ichimura T., E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein Journal of Virology 2007 81 3 1174 1185
34. Dharancy S., Malapel M., Perlemuter G., Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection Gastroenterology 2005 128 2 334 342
35. Cheng Y., Dharancy S., Malapel M., Desreumaux P., Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor α and carnitine palmitoyl acyl-CoA transferase 1A World Journal of Gastroenterology 2005 11 48 7591 7596
36. De Gottardi A., Pazienza V., Pugnale P., Peroxisome proliferator- activated receptor- α and-γ mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection Alimentary Pharmacology and Therapeutics 2006 23 1 107 114
37. Rakic B., Sagan S. M., Noestheden M., Peroxisome proliferator-activated receptor α antagonism inhibits hepatitis C virus replication Chemistry and Biology 2006 13 1 23 30